56509-88-7|Viridinomycin|(4E,6E,8E,10Z,16Z,18Z,20E,22E,24R,25S,26R)-25,27-dihydroxy-26-methoxy-4,24-dimethyl-13-phenyl-3-oxa-14-azabicyclo[22.3.0]heptacosa-1(27),4,6,8,10,16,18,20,22-nonaene-2,15-dione|-范德生物科技公司

Viridinomycin

NMR下载 COA and HPLC MSDS下载
names：
(4E,6E,8E,10Z,16Z,18Z,20E,22E,24R,25S,26R)-25,27-dihydroxy-26-methoxy-4,24-dimethyl-13-phenyl-3-oxa-14-azabicyclo[22.3.0]heptacosa-1(27),4,6,8,10,16,18,20,22-nonaene-2,15-dione
CAS号：
56509-88-7
MDL Number：
MF(分子式)： C34H37NO6 MW(分子量)： 555.671
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	(4E,6E,8E,10Z,16Z,18Z,20E,22E,24R,25S,26R)-25,27-dihydroxy-26-methoxy-4,24-dimethyl-13-phenyl-3-oxa-14-azabicyclo[22.3.0]heptacosa-1(27),4,6,8,10,16,18,20,22-nonaene-2,15-dione
英文别名	Viridinomycin; Viridomycin; Antibiotic T-24146; Viridenomycin
CAS号	56509-88-7
Inchi	InChI=1S/C34H37NO6/c1-25-19-13-8-4-5-9-16-22-27(26-20-14-12-15-21-26)35-28(36)23-17-10-6-7-11-18-24-34(2)29(33(39)41-25)30(37)31(40-3)32(34)38/h4-21,23-24,27,31-32,37-38H,22H2,1-3H3,(H,35,36)/b5-4+,10-6-,11-7+,13-8+,16-9-,23-17-,24-18+,25-19+/t27?,31-,32+,34+/m0/s1
InchiKey	GWYPHKYSRIAIBU-KGZNJIQESA-N
分子式 Formula	C34H37NO6
分子量 Molecular Weight	555.671
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Viridinomycin(CAS:56509-88-7):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Viridinomycin is a crystalline antibiotic that shows strong activity against Trichomonas vaginalis and gram-positive bacteria.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Batsanov AS, Knowles JP, Lightfoot AP, Maw G, Thirsk CE, Twiddle SJ, Whiting A. A novel, efficient, diastereo- and enantioselective Mukaiyama aldol-based synthesis of a vinyl cyclopentanone core derivative of viridenomycin. Org Lett. 2007 Dec 20;9(26):5565-8. Epub 2007 Nov 17. PubMed PMID: 18020354.

[2]Hasegawa T, Kamiya T, Henmi T, Iwasaki H, Yamatodani S. Viridenomycin, a new antibiotic. J Antibiot (Tokyo). 1975 Mar;28(3):167-75. PubMed PMID: 1079209.

[3] Knowles JP, O'Connor VE, Whiting A. Studies towards the synthesis of the northern polyene of viridenomycin and synthesis of Z-double bond analogues. Org Biomol Chem. 2011 Mar 21;9(6):1876-86. doi: 10.1039/c0ob00977f. Epub 2011 Jan 31. PubMed PMID: 21283899.

[4] Batsanov AS, Knowles JP, Whiting A. Mechanistic studies on the Heck-Mizoroki cross-coupling reaction of a hindered vinylboronate ester as a key approach to developing a highly stereoselective synthesis of a C1-C7 Z,Z,E-triene synthon for viridenomycin. J Org Chem. 2007 Mar 30;72(7):2525-32. Epub 2007 Mar 3. PubMed PMID: 17335239.

[5] Nakagawa M, Toda Y, Furihata K, Hayakawa Y, Seto H. Studies on viridenomycin, a novel 24-membered macrocyclic polyene lactam antibiotic. J Antibiot (Tokyo). 1992 Jul;45(7):1133-8. PubMed PMID: 1517159.

6: Trost BM, Jiang C. Pd-catalyzed asymmetric allylic alkylation. A short route to the cyclopentyl core of viridenomycin. Org Lett. 2003 May 1;5(9):1563-5. PubMed PMID: 12713324.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开